BIOS Health

BIOS Health is a Spinal & Peripheral Interfaces company founded in 2019 and based in Cambridge, United Kingdom.

Reads and modulates the vagus nerve to treat chronic inflammatory diseases using implantable neural interfaces. Raised $35M Series A in 2023. Platform targets rheumatoid arthritis, Crohn's disease, and other inflammatory conditions. Early clinical trials underway.

Pioneering bioelectronic medicine with a focus on the peripheral nervous system, demonstrating that neural interfaces extend well beyond the brain to whole-body health applications.

bios.health Spinal & Peripheral Interfaces

United Kingdomprivate

At a glance

Total raised

Undisclosed

no public funding on record

Headcount

11-50

approximate · public range

Headquarters

Cambridge

United Kingdom

Founded

2019

7 years active

Status

Private

Spinal & Peripheral Interfaces

Subsector

Funding history

Total raised

—

Rounds tracked

Latest stage

Series A

Date	Stage	Amount	Valuation	Lead investors
Jun 22, 2023	Series A	—	—	Selvedge Venture, XTX Ventures
Jan 1, 2018	Seed	—	—	Real Ventures, AME Cloud Ventures

BIOS Health

At a glance

Funding history

In the news

Leadership

Products

Neural Interface Platform

Open roles

Compare BIOS Health with